ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 291

$1.49M Total Retail Price of All Prescriptions

Rank: 11 out of 291

641 Patients Receiving at Least One Drug in Part D
55% Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in West Virginia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

16% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

37% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 1,546 661 217 S3 1 1
LEVOTHYROXINE SODIUM 924 624 133 2 2
GABAPENTIN 766 282 154 3 12
OMEPRAZOLE 695 370 115 4 4
ALPRAZOLAM 646 297 95 B 5 14
SIMVASTATIN 581 313 91 6 5
METFORMIN HCL 500 218 88 7 9
ATORVASTATIN CALCIUM 465 255 92 8 8
FUROSEMIDE 443 302 97 9 6
PRAVASTATIN SODIUM 437 228 81 10 16
MONTELUKAST SODIUM 432 266 75 11 29
LISINOPRIL 428 209 85 12 3
OXYCODONE HCL 416 130 55 S2 13 46
METOPROLOL SUCCINATE 392 235 61 14 13
AMLODIPINE BESYLATE 386 228 77 15 7
LOSARTAN POTASSIUM 382 207 72 16 21
CLONAZEPAM 381 172 55 B 17 37
CLOPIDOGREL 366 201 60 18 11
RANITIDINE HCL 342 156 65 19 33
METOPROLOL TARTRATE 340 192 68 20 10
GLIMEPIRIDE 339 176 55 21 31
NEXIUM 335 153 54 22 20
CRESTOR 326 168 58 23 23
ATENOLOL 321 215 55 24 19
TRAMADOL HCL 260 110 64 25 24
ZOLPIDEM TARTRATE 257 105 47 26 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 253 100 48 27 35
CARVEDILOL 250 146 44 28 25
CITALOPRAM HBR 248 132 47 29 27
PROAIR HFA 244 89 65 30 36
CLONIDINE HCL 216 81 42 31 53
ALLOPURINOL 215 140 42 32 41
DIAZEPAM 213 79 34 B 33 55
WARFARIN SODIUM 208 105 37 34 15
CYMBALTA 198 57 35 35 40
PANTOPRAZOLE SODIUM 184 136 45 36 28
SPIRIVA 180 71 33 37 56
LOSARTAN-HYDROCHLOROTHIAZIDE 179 109 30 38 52
HYDROCHLOROTHIAZIDE 176 83 39 39 18
LORAZEPAM 165 92 26 B 40 22
FLUTICASONE PROPIONATE 164 75 44 41 50
OXYCODONE HCL-ACETAMINOPHEN 160 35 29 S2 42 70
TOPIRAMATE 159 22 28 43 140
MELOXICAM 151 94 38 44 38
TIZANIDINE HCL 151 37 32 44 114
SERTRALINE HCL 148 67 30 46 26
PREDNISONE 144 80 42 47 42
CYCLOBENZAPRINE HCL 142 43 43 R 48 84
MIRTAZAPINE 140 114 31 49 66
TAMSULOSIN HCL 139 75 27 50 30
PAROXETINE HCL 138 56 24 51 65
TRAZODONE HCL 135 36 28 52 48
ISOSORBIDE MONONITRATE ER 127 90 24 53 39
SUBOXONE 123 <11 <11 S3 54 156
KLOR-CON M10 122 91 34 55 95
ROPINIROLE HCL 119 40 21 56 62
QUETIAPINE FUMARATE 118 36 19 A 57 63
SPIRONOLACTONE 114 48 22 58 68
COMBIVENT RESPIMAT 114 43 25 58 230
FLUOXETINE HCL 110 20 19 60 74
AMITRIPTYLINE HCL 109 36 24 R 61 85
ESCITALOPRAM OXALATE 108 65 18 62 44
SYNTHROID 104 58 19 63 49
LYRICA 102 51 19 64 72
KLOR-CON M20 99 52 18 65 45
LOVAZA 99 17 16 65 110
ADVAIR DISKUS 98 33 29 67 51
VENLAFAXINE HCL ER 97 16 19 68 92
BACLOFEN 96 27 24 69 146
TEMAZEPAM 96 39 18 B 69 88
TRIAMTERENE-HCTZ 94 70 17 71 64
DONEPEZIL HCL 93 78 19 72 34
AZITHROMYCIN 92 52 70 73 54
FENTANYL 90 26 12 S2 74 87
ENALAPRIL MALEATE 88 17 13 75 80
LANTUS SOLOSTAR 87 21 26 76 83
NOVOLOG FLEXPEN 86 20 26 77 177
INSULIN SYRINGE* 86 20 19 77 134
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 51 54 77 104
GLIPIZIDE XL 84 51 17 80 138
FENOFIBRATE* 84 30 15 80 60
PROMETHAZINE HCL 84 47 17 R 80 120
CEPHALEXIN 79 37 67 83 97
ONDANSETRON HCL* 78 39 24 84 168
RAMIPRIL 78 51 14 84 94
POTASSIUM CHLORIDE 77 27 20 86 17
SYMBICORT 75 32 19 87 96
HYDROXYZINE PAMOATE 75 29 17 R 87 213
VALSARTAN-HYDROCHLOROTHIAZIDE 71 35 13 89 98
GEMFIBROZIL 70 41 17 90 136
ZETIA 69 23 14 91 58
IBUPROFEN 68 12 22 92 90
DOXYCYCLINE HYCLATE 67 25 40 93 174
VERAPAMIL ER 66 18 12 94 141
OXYBUTYNIN CHLORIDE 66 32 17 94 126
GLIPIZIDE ER 66 50 12 94 156
TORSEMIDE 64 <11 <11 97 109
METOCLOPRAMIDE HCL 63 13 15 98 151
DIOVAN 63 <11 <11 98 47
MORPHINE SULFATE ER 62 <11 <11 S2 100 117
PRADAXA 62 <11 <11 100 160
BD ULTRA-FINE PEN NEEDLE 61 26 30 102 106
GLIPIZIDE 60 23 14 103 59
JANUMET 60 <11 <11 103 189
CIPROFLOXACIN HCL 58 34 48 105 73
JANUVIA 57 38 13 106 57
OXYCODONE-ACETAMINOPHEN 56 14 20 S2 107 76
LANSOPRAZOLE 55 24 11 108 112
BUMETANIDE 55 15 11 108 149
LEVEMIR FLEXPEN 53 26 18 110 129
BUSPIRONE HCL 52 25 20 111 123
FLUCONAZOLE 52 23 29 111 145
AMOXICILLIN 51 34 43 113 99
TERAZOSIN HCL 51 46* 11 113 165
FINASTERIDE 50 <11 <11 115 102
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.